Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236.8 CHF | -1.00% | 0.00% | -9.41% |
Apr. 25 | The specter of stagflation rears its ugly head again | |
Apr. 25 | ROCHE : Barclays lowers target price | CF |
Sales 2024 * | 60B 65.75B | Sales 2025 * | 63.83B 69.95B | Capitalization | 176B 193B |
---|---|---|---|---|---|
Net income 2024 * | 13.31B 14.59B | Net income 2025 * | 14.75B 16.17B | EV / Sales 2024 * | 3.18 x |
Net Debt 2024 * | 14.24B 15.6B | Net Debt 2025 * | 8.17B 8.95B | EV / Sales 2025 * | 2.89 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
11.7
x | Employees | 103,605 |
Yield 2024 * |
4.44% | Yield 2025 * |
4.6% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -1.00% | ||
Current month | -2.55% | ||
1 month | -0.67% | ||
3 months | -8.36% | ||
6 months | -6.55% | ||
Current year | -9.41% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.06% | 2 M€ | -.--% | - | |
2.06% | 2 M€ | +9.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 236.8 | -1.00% | 41,602 |
24-04-24 | 239.2 | -4.40% | 32,173 |
24-04-23 | 250.2 | +2.46% | 49,199 |
24-04-22 | 244.2 | +2.61% | 41,027 |
24-04-19 | 238 | +0.51% | 21,595 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-12.26% | 149B | |
-6.47% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- ROG Stock
- RO Stock